Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO KEY INTERNATIONAL INC Director's Dealing 2021

Aug 20, 2021

35397_dirs_2021-08-20_60c6650f-af75-42f3-8e16-148afdac3e7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO KEY INTERNATIONAL INC (BKYI)
CIK: 0001019034
Period of Report: 2021-08-19

Reporting Person: Sullivan James David (Chief Legal Officer, SVP Strategy & Compliance)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-19 Common Stock P 2000 $3.10 Acquired 22000 Direct
2021-08-19 Common Stock P 3000 $2.92 Acquired 25000 Direct